Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Biotechnology  22, 707 - 716 (2004)
Published online: 16 May 2004; | doi:10.1038/nbt971

Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation

Ralph Brandenberger1, Henry Wei1, Sally Zhang1, 4, Shirley Lei1, 4, Jaji Murage1, 4, Gregory J Fisk1, Yan Li1, Chunhui Xu1, Rixun Fang2, 4, Karl Guegler2, 4, Mahendra S Rao3, Ramumkar Mandalam1, Jane Lebkowski1 & Lawrence W Stanton1, 4

1  Geron Corporation, 230 Constitution Drive, Menlo Park, California 94025, USA.

2  Celera Genomics, 45 West Gude Drive, Rockville, Maryland 20850, USA.

3  National Institute on Aging, 5600 Nathan Shock Drive, Baltimore, Maryland 21224, USA.

4  Present addresses: Transplantation Immunology, Department of Cardiothoracic Surgery, Stanford University, Stanford, California 94305, USA (S.Z.), UCSF School of Dentistry, 513 Parnassus Avenue, S-630, San Francisco, California 94143-0430, USA (S.L.), Molecular Pharmacology, Stanford University, 269 Campus Drive, CCSR 3230, Stanford, California 94305, USA (J.M.), Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA (R.F., K.G.), Genome Institute of Singapore, 60 Biopolis Street, Singapore 138672 (L.W.S.).

Correspondence should be addressed to Ralph Brandenberger rbrandenberger@geron.com
Human embryonic stem (hES) cells hold promise for generating an unlimited supply of cells for replacement therapies. To characterize hES cells at the molecular level, we obtained 148,453 expressed sequence tags (ESTs) from undifferentiated hES cells and three differentiated derivative subpopulations. Over 32,000 different transcripts expressed in hES cells were identified, of which more than 16,000 do not match closely any gene in the UniGene public database. Queries to this EST database revealed 532 significantly upregulated and 140 significantly downregulated genes in undifferentiated hES cells. These data highlight changes in the transcriptional network that occur when hES cells differentiate. Among the differentially regulated genes are several components of signaling pathways and transcriptional regulators that likely play key roles in hES cell growth and differentiation. The genomic data presented here may facilitate the derivation of clinically useful cell types from hES cells.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2004 Nature Publishing Group | Privacy policy